| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC2355 |
| Trial ID | NCT04385173 |
| Disease | Glioblastoma |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B7-H3 CAR-T cells |
| Co-treatment | Temozolomide |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Other ID(s) | SAHZJU-BP102 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||